| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3875461 | The Journal of Urology | 2007 | 4 Pages |
Abstract
Treatment of interstitial cystitis with duloxetine did not result in significant improvement of symptoms. The drug administration was safe but the tolerability of the drug was poor mainly due to nausea occurring with the starting dose of 20 mg per day. Based on the preliminary data of this observational trial we currently cannot recommend duloxetine as a therapeutic approach for interstitial cystitis.
Keywords
VAS5-HTSUIQmaxPDNglobal response assessmentGRAStress urinary incontinenceInterstitialmaximum urinary flow ratePelvic painDuloxetineCystitisInterstitial cystitisInterstitial Cystitis Symptom Indexadverse eventAntidepressive agentsvisual analog scaleICSInoradrenalinePeripheral diabetic neuropathyClinical trial
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Arndt van Ophoven, Lothar Hertle,